Official websites use .gov
A
.gov
website belongs to an official government organization in the
United States.
Secure .gov websites use HTTPS
A
lock
(
) or
https://
means you’ve safely connected to the .gov website. Share sensitive
information only on official, secure websites.
PubMed ID:
36547967
Public Release Type:
Journal
Publication Year: 2023
Affiliation: Wisconsin Reading Center, Department of Ophthalmology, University of Wisconsin School of Medicine and Public and Health, Madison.; Wisconsin Reading Center, Department of Ophthalmology, University of Wisconsin School of Medicine and Public and Health, Madison.; Department of Statistics, George Washington University, Washington, DC.; Department of Epidemiology, University of Colorado School of Public Health, Denver.; Department of Medicine, Ronald Reagan UCLA Medical Center, Los Angeles, California.; Diabetes Epidemiology and Clinical Research Section, National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, Arizona.; Division of Diabetes, Endocrinology, and Metabolic Diseases, National Institutes of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland.; Department of Medicine, Columbia University Medical Center, New York, New York.; Division of Endocrinology & Diabetes, Department of Pediatrics, Washington University in St Louis School of Medicine, St Louis, Missouri.; Division of Epidemiology and Clinical Applications-Clinical Trials Branch, National Eye Institute - National Institutes of Health, Bethesda, Maryland.
DOI:
https://doi.org/10.1001/jamaophthalmol.2022.5567
Authors:
Domalpally Amitha, Whittier Samuel A, Pan Qing, Dabelea Dana M, Darwin Christine H, Knowler William C, Lee Christine G, Luchsinger Jose A, White Neil H, Chew Emily Y
Request IDs:
21434
Studies:
Diabetes Prevention Program Outcomes Study
Age-related macular degeneration (AMD) is a leading cause of blindness with no treatment available for early stages. Retrospective studies have shown an association between metformin and reduced risk of AMD.
